ATP release and contraction mediated by different P2-receptor subtypes in guinea-pig ileal smooth muscle
Open Access
- 1 August 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (8), 1744-1748
- https://doi.org/10.1038/sj.bjp.0701329
Abstract
1 The present study was addressed to clarify the subtypes of P2‐purinoceptor involved in ATP release and contraction evoked by α,β‐methylene ATP (α,β‐mATP) and other P2‐agonists in guinea‐pig ileum. 2 α,β‐mATP 100 μM produced a transient and steep contraction followed by ATP release from tissue segments. These maximum responses appeared with different time‐courses and their ED50 values were 5 and 25 μM, respectively. The maximum release of ATP by α,β‐mATP was markedly reduced by 250 μM suramin, 30 μM pyridoxal‐phosphate‐6‐azophenyl‐2′,5′‐disulphonic acid (PPADS) and 30 μM reactive blue 2 (RB‐2), P2‐receptor antagonists. However, the contractile response was inhibited by suramin, tetrodotoxin and atropine, but not by PPADS and RB‐2. 3 Although the contraction caused by α,β‐mATP was strongly diminished by Ca2+‐removal and nifedipine, and also by tetrodotoxin and atropine at 0.3 μM, the release of ATP was virtually unaffected by these procedures. 4 UTP, β,γ‐methylene ATP (β,γ‐mATP) and ADP at 100 μM elicited a moderate release of ATP. The release caused by UTP was virtually unaffected by RB‐2. However, these P2‐agonists failed to elicit a contraction of the segment. 5 The potency order of all the agonists tested for the release of ATP was α,β‐mATP>UTP>β,γ‐mATP>ADP. 6 In superfusion experiments with cultured smooth muscle cells from the ileum, α,β‐mATP (100 μM) enhanced the release of ATP 5 fold above the basal value. This evoked release was inhibited by RB‐2. 7 These findings suggest that ATP release and contraction induced by P2‐agonists such as α,β‐mATP in the guinea‐pig ileum result mainly from stimulation of different P2‐purinoceptors, P2Y‐like purinoceptors on the smooth muscles and, probably, P2X‐purinoceptors on cholinergic nerve terminals, respectively. However, the ATP release may also be mediated, in part, by P2U‐receptors, because UTP caused RB‐2‐insensitive ATP release. British Journal of Pharmacology (1997) 121, 1744–1748; doi:10.1038/sj.bjp.0701329Keywords
This publication has 21 references indexed in Scilit:
- Towards a revised nomenclature for P1 and P2 receptorsTrends in Pharmacological Sciences, 1997
- Numbering of cloned P2 purinoceptorsDrug Development Research, 1996
- PPADS: an antagonist at endothelial P2Y‐purinoceptors but not P2U‐purinoceptorsBritish Journal of Pharmacology, 1995
- Differential effects of P2‐purinoceptor antagonists on phospholipase C‐ and adenylyl cyclase‐coupled P2Y‐purinoceptorsBritish Journal of Pharmacology, 1994
- Evidence for the presence of two types of P2 purinoceptor in the guinea-pig ileal longitudinal smooth muscle preparationEuropean Journal of Pharmacology, 1994
- Postjunctional ATP release mediated by stimulation of P2x-purinoceptorsThe Japanese Journal of Pharmacology, 1992
- Increased flow‐induced ATP release from isolated vascular endothelial cells but not smooth muscle cellsBritish Journal of Pharmacology, 1991
- 3 possible coupling of postjunctional ATP release and transmitters' receptor stimulation in smooth musclesLife Sciences, 1990
- Suramin antagonizes responses to P2‐purinoceptor agonists and purinergic nerve stimulation in the guinea‐pig urinary bladder and taenia coliBritish Journal of Pharmacology, 1990
- P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y- but not the P2x-purinoceptorBritish Journal of Pharmacology, 1987